Breaking: Capricor Therapeutics, Inc. (CAPR) Spike Almost 400% The share price of Capricor Therapeutics, Inc. (CAPR) saw a noteworthy uptick of almost 400% in Wednesday's market session breaking out of a bullish flag pattern. The asset is gearing for a move to the $50 resistant amidst market condition.
In another recent news, which could be the precursor to the recent surge, Capricor Therapeutics ( NASDAQ:CAPR ), said on Wednesday its cell therapy for a rare muscular disorder met the main goal of a late-stage study, reviving hopes for U.S. approval after a setback and sending its shares up more than four-fold.
Shares of the San Diego-based company soared 328% to $27.25, on track to add about $955 million in market value, if gains hold.
Financial Performance
In 2024, Capricor Therapeutics's revenue was $22.27 million, a decrease of -11.55% compared to the previous year's $25.18 million. Losses were -$40.47 million, 81.6% more than in 2023.
About CAPR
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD.
CAPR
CAPR projected to see additional volatility NEAR TERM. Recent short attack will likely be a two-part process.
Expecting strong buy wave to 17-18.5 zone near term before renewed aggressive selling down to next liquidity target zone at 10.4-11 level.
There exists a small gap at 9.95-10.05 which may be targeted by shorts. Unsure if it gets filled during market hrs or during extended session.
Planning to go long again from 10.4-11 via limit buy orders sometime this month. Expecting us to get the buy opportunity before 12/20 date before the next swing target to 25.00
once we see a break above 26.5, it'll confirm for me the greater buy sequence will continue on weekly timeframe for advancement to 75-80$ analyst target level. Until then, we may remain rangebound between 15-25$ levels.
Personally expecting price to reach 100$ sometime by late 2025.
$CAPR Target 7.55 for 42.99%$CAPR Target 7.55 for 42.99%
Or double position at 3.01
RSI Support Bounce — Let’s go all the way…
I have not added since last chart and target is the same.
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible.
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed.
GL and happy trading.
I finally added my YouTube Training Video to my profile tagline since I’m not allowed to on here. It’s a quick 15 minute training video on how to set up your chart and how to spot opportunities. So check here first but If you have questions just message me.
ADDED to $CAPR New Target 7.61 for 42.51% $CAPR Target 7.61 for 42.51%
Or next add level is at 3.07
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible.
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed.
GL and happy trading.
ADDED to $CAPR NEW Target 7.74 for 41.50% $CAPR Target 7.74 for 41.50%
Or next add level is at 3.20
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible.
I am not your financial advisor. Watch my setups first before you jump in… My trade set ups work very well and they are for my personal reference and if you decide to trade them you do so at your own risk. I will gladly answer questions to the best of my knowledge but ultimately the risk is on you. I will update targets as needed.
GL and happy trading.
NNVC -- You Knew That Was Going to Spike AgainThat shaded box, starting from January.19th, was most likely somebody accumulating..
But it looks like the usual suspects, that being:
Sabby Management
Altrium Capital
Empery Asset Management
CVI Investments
all somehow managed to miss out on this one at the exact same time, because according to the their end of year 13-G reports, they all reported 0% ownership in the company...
At times, it seems like the line between hedge fund and underwriter has become blurred with these companies, where it almost looks like they are cooperating with the underwriter during the equity offering process -- but who knows..
Something about this was mentioned in an sec litigation a few years back.
“The SEC alleges that a former day trader living in California, Steven Fishoff, schemed with two friends and his brother-in-law to pose as legitimate portfolio managers and induce investment bankers to bring them “over the wall” and share confidential information about an upcoming secondary offering. After promising they wouldn’t disclose the nonpublic information to others or trade an issuer’s stock before an offering was announced, they violated the agreements and tipped each other about the upcoming offerings expected to inherently depress the price of the issuer’s stock. The tippees then shorted the stock before an offering was publicly announced and assured themselves profits on the short sales after the stock price dropped”.
Are New Highs In Store For CAPR?One of the penny stocks to watch due to its recent performance is that of Capricor Therapeutics Inc (CAPR Stock Report). Back on September 24, the company had been granted a meeting by the United States Food and Drug Administration.
" Shares gained as much as 20% as Capricor stock started the week with a bang. It is one of the biotech penny stocks that have performed impressively over recent days. Obviously with news like this and the type of momentum CAPR stock is seeing, many will have it on their watch lists for the week.
"
Source: 3 Penny Stocks To Buy or Sell In October?
CAPR - Fallen angel breakout long from $1.53 to $2.57CARP is a advanced/aggressive long setup. It has broken out on huge volume yesterday and forming a flag formation in hourly frame. We think it has further upside potential.
* Trade Criteria *
Date First Found- July 18, 2017
Pattern/Why- Fallen angel breakout Long (advanced/aggressive setup)
Entry Target Criteria- Break of $1.53
Exit Target Criteria- $1.83, $1.87, 2nd Target $2.57
Stop Loss Criteria- $1.24
Please check back for Trade updates. (Note: Trade update is little delayed here.)











